TILL TRANSAKTIONER
Finansiella tjänster

Bci has completed a capital increase

Banco de Crédito e Inversiones (Bci) has raised funds to support its local and international growth strategy and strengthen the company’s financial position to comply with the latest required regulatory capital ratios (Basel III).

Banco de Crédito e Inversiones, headquartered in Santiago, Chile, is a subsidiary of Empresas Juan Yarur S.P.A. and is Bci’s solid growth strategy has positioned the company as the largest bank in Chile and eighth largest bank in Latin America in terms of assets. Bci was incorporated in 1937.

Oaklins’ team in Chile acted as financial co-advisor and placement co-agent for the capital increase.

Prata med transaktionsteamet

Raimundo Silva

Partner
Santiago, Chile
Oaklins LarrainVial

Cristobal Tagle

Senior Analyst
Santiago, Chile
Oaklins LarrainVial

Relaterade transaktioner

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

Lär dig mer
Buydepa has completed an IPO through ScaleX
Andra industrier | Fastigheter

Buydepa has completed an IPO through ScaleX

Buydepa S.p.A. has successfully raised US$3.1 million (CLP3 billion) through its stock market debut on ScaleX (Santiago Venture Exchange). The company placed 12% of its shares through a capital increase, with subscriptions from a local institutional investor and a broad base of high-net-worth qualified investors.

Lär dig mer
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Hälsovård

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Lär dig mer